Latest COLL reports update at 2024-02-22: 202320222021
Collegium Pharmaceutical logo

Collegium Pharmaceutical COLL

$ 36.42 1.62%

Country

usaUSA

IPO year

2015

Industry

Drug manufacturers

Stock Exchange

NASDAQ GLOBAL

CEO

Mr. Joseph Ciaffoni

Employees in the company

255

Shares

32.3 M

Market Cap[1]

$ 1.18 B

EBITDA (LTM)

$ 238 M

P/E (LTM)

44.43

P/S (LTM)

1.34

EPS (LTM)

0.49

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.